Skip to main content
. 2024 Jun 18;15:1379056. doi: 10.3389/fimmu.2024.1379056

Table 4.

Response of visceral disease and bone disease to immune checkpoint inhibitors.

Visceral Disease Bone Disease
Progressive Disease, n (%) 167 (29.1) 140 (57.6)
Stable Disease, n (%) 152 (26.5) 55 (22.6)
Partial Response, n (%) 145 (25.3) 47 (19.3)
Complete Response, n (%) 0 0

Visceral disease measured retrospectively with RECIST criteria; bone disease measured with MD Anderson criteria.

Significant discordance between visceral disease response and bone disease response was identified, p=0.047.